Literature DB >> 2411177

Breathing during sleep in patients with interstitial lung disease.

R Perez-Padilla, P West, M Lertzman, M H Kryger.   

Abstract

Patients with interstitial lung disease (ILD) have a rapid shallow breathing pattern while awake that is thought to be due to activation of lung reflexes. We wondered whether sleep would result in changes in respiratory control and thus cause hypoxemia and poor sleep quality. Eleven patients with ILD (5 men and 6 women) and 11 age- and sex-matched control subjects were studied during sleep. Sleep quality was worse in patients with ILD, with more time in Stage 1 (33.7% of total sleep time (TST) versus 13.5%) and less time in REM sleep (11.8 versus 19.9% TST) than found in control subjects, and more fragmentation of sleep (13.7 +/- 3.1 arousals/h and 24.3 +/- 6.0 sleep stage changes/h versus 6.9 +/- 1.0 and 12.7 +/- 1.4, respectively). Patients with ILD with awake SaO2 less than 90% had greater abnormalities in sleep structure than did those with SaO2 greater than 90%. The incidence of apneas and hypopnea periods in patients with ILD was low (apnea plus hypoventilation index of 1.3 +/- 0.45 versus 2.9 +/- 0.82 in control subjects, p = NS). Oxygen saturation dropped during REM sleep in patients, especially in those with more severe awake hypoxemia. Expiratory time (Te), inspiratory time (Ti), and their sum (Ttot) were shorter in the patients, whereas Ti/Ttot was the same as in control subjects. No systematic changes during sleep were seen in these variables. The variability of inspiratory volume index, Ti, Te, and Ti/Ttot was similar to that in control subjects, and was lowest during NREM sleep. The incidence of snoring was comparable in patients and control subjects.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2411177     DOI: 10.1164/arrd.1985.132.2.224

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  26 in total

1.  A survey of nocturnal hypoxaemia and health related quality of life in patients with cryptogenic fibrosing alveolitis.

Authors:  M Clark; B Cooper; S Singh; M Cooper; A Carr; R Hubbard
Journal:  Thorax       Date:  2001-06       Impact factor: 9.139

2.  Commentary on How common is sleep-disordered breathing in patients with idiopathic pulmonary fibrosis? Mermigkis C. et al.

Authors:  Karl-Heinz Ruhle
Journal:  Sleep Breath       Date:  2010-03-16       Impact factor: 2.816

3.  Sleep oxygen desaturation predicts survival in idiopathic pulmonary fibrosis.

Authors:  Likurgos Kolilekas; Effrosyni Manali; Katerina A Vlami; Panagiotis Lyberopoulos; Christina Triantafillidou; Konstantinos Kagouridis; Katerina Baou; Sotirios Gyftopoulos; Konstantinos N Vougas; Anna Karakatsani; Manos Alchanatis; Spyros Papiris
Journal:  J Clin Sleep Med       Date:  2013-06-15       Impact factor: 4.062

4.  Obstructive sleep apnea is common in idiopathic pulmonary fibrosis.

Authors:  Lisa H Lancaster; Wendi R Mason; James A Parnell; Todd W Rice; James E Loyd; Aaron P Milstone; Harold R Collard; Beth A Malow
Journal:  Chest       Date:  2009-06-30       Impact factor: 9.410

5.  Obstructive sleep apnea in patients with interstitial lung diseases: past and future.

Authors:  Charalampos Mermigkis; Izolde Bouloukaki; Sophia E Schiza
Journal:  Sleep Breath       Date:  2013-04-12       Impact factor: 2.816

6.  Sleep in patients with large pleural effusion: impact of thoracentesis.

Authors:  Bianca Fernandes Marcondes; Francisco Vargas; Fabio Henrique Paschoal; Ana Maria Cartaxo; Lisete R Teixeira; Eduardo Henrique Genofre; Roberto Onishi; Robert Skomro; Geraldo Lorenzi-Filho
Journal:  Sleep Breath       Date:  2011-05-15       Impact factor: 2.816

7.  Long-term oxygen therapy in patients with diagnoses other than COPD.

Authors:  C F Donner; A Braghiroli; F Ioli; S Zaccaria
Journal:  Lung       Date:  1990       Impact factor: 2.584

8.  Sleep disorders and health-related quality of life in patients with interstitial lung disease.

Authors:  Maria Mavroudi; Despoina Papakosta; Theodore Kontakiotis; Kaliopi Domvri; George Kalamaras; Vasiliki Zarogoulidou; Paul Zarogoulidis; Paschalina Latka; Haidong Huang; Wolfgang Hohenforst-Schmidt; Konstantinos Zarogoulidis
Journal:  Sleep Breath       Date:  2017-10-16       Impact factor: 2.816

9.  Ventilation and gas exchange during sleep in patients with interstitial lung disease.

Authors:  W T McNicholas; M Coffey; M X Fitzgerald
Journal:  Thorax       Date:  1986-10       Impact factor: 9.139

10.  Endothelin-1 levels in interstitial lung disease patients during sleep.

Authors:  Georgia Trakada; Eugenia Nikolaou; Athanasia Pouli; Maria Tsiamita; Kostas Spiropoulos
Journal:  Sleep Breath       Date:  2003-09       Impact factor: 2.816

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.